ACUTA CAPITAL PARTNERS, LLC - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 42 filers reported holding NABRIVA THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q1 2018$2,815,000
-18.8%
559,739
-3.5%
0.46%
-29.8%
Q4 2017$3,468,000
+5.9%
580,000
+45.0%
0.66%
+11.6%
Q3 2017$3,276,000
-66.9%
400,000
-57.7%
0.59%
-78.8%
Q2 2017$9,911,000–945,737–2.77%–
 Download
Other shareholders
NABRIVA THERAPEUTICS PLC shareholders Q2 2018
NameSharesValueWeighting ↓
Aisling Capital Management LP 191,028$462,0000.08%
Sterling Investment Advisors, Ltd. 5,000$12,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of NABRIVA THERAPEUTICS PLC shareholders